HopeStage
Back to all studies
Active Not RecruitingNCT07164755

Measurement of Serum Inflammatory Markers in Patients Treatment-resistant Depression Given Psilocybin

Observational studyAges 25–80United Kingdom
The study in practice

Understand this study

Who could participate?

Listed age limits: 25 years to 80 years.

Listed locations
LondonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 21, 2021
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
46
Sponsor
King's College London
Sponsor type
University
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United Kingdom
Age range
From 25 Years to 80 Years
Official registry ID
NCT07164755
Official title
Show the full official title

Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.

Recruitment & locations

Not recruiting

London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is King's College London, a university.

Who can participate?

Listed age limits: 25 years to 80 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies